Literature DB >> 16037517

Prognostic value of the standardized uptake value in esophageal cancer.

Henderik L van Westreenen1, John T M Plukker, David C P Cobben, Carolien J M Verhoogt, Henk Groen, Pieter L Jager.   

Abstract

OBJECTIVE: On PET, the level of tissue glycolysis can be quantified by the accumulation of fluorine-18-fluorodeoxyglucose expressed as the standardized uptake value (SUV). The aims of this study were to investigate the relation between SUV and the stage of disease and whether SUV can be used to predict resectability and survival in patients with esophageal cancer.
CONCLUSION: SUV can be used to predict resectability; however, SUV is not an independent factor that can be used to assess survival in patients with esophageal cancer.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16037517     DOI： 10.2214/ajr.185.2.01850436

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN： 0361-803X            Impact factor:   3.959


  24 in total

1.  Accuracy of PET-CT in predicting survival in patients with esophageal cancer.

Authors:  Claire Brown; Ben Howes; Glyn G Jamieson; Dylan Bartholomeusz; Urs Zingg; Thomas R Sullivan; Sarah K Thompson
Journal:  World J Surg       Date:  2012-05       Impact factor: 3.352

2.  PET: other thoracic malignancies.

Authors:  Leslie E Quint
Journal:  Cancer Imaging       Date:  2006-10-31       Impact factor: 3.909

3.  Clinical significance of primary lesion FDG uptake for choice between oesophagectomy and endoscopic submucosal dissection for resectable oesophageal squamous cell carcinomas.

Authors:  Masatoyo Nakajo; Masayuki Nakajo; Atsushi Tani; Yoriko Kajiya; Shunji Shimaoka; Akio Matsuda; Tatsuyuki Nioh; Tohru Nihara; Toyokuni Suenaga; Sadao Tanaka; Hiroshi Shirahama; Michiyo Higashi; Chihaya Koriyama
Journal:  Eur Radiol       Date:  2011-07-13       Impact factor: 5.315

4.  Significance of 18F-Fluorodeoxyglucose Uptake at the Gastroesophageal Junction: Comparison of PET to Esophagogastroduodenoscopy.

Authors:  Joshua Stagg; Irfan Farukhi; Francisco Lazaga; Chiarra Thompson; Ledjona Bradshaw; Mohamed Kaif; Aron Gould-Simon; Robert Schmidt
Journal:  Dig Dis Sci       Date:  2014-12-14       Impact factor: 3.199

5.  Prognostic value of pre-treatment maximum standardized uptake value and CRP in radiotherapy of esophageal cancer.

Authors:  Haruka Jinnouchi; Hideomi Yamashita; Tomoki Kiritoshi; Yosuke Miki; Atsuto Katano; Keiichi Nakagawa; Osamu Abe
Journal:  Mol Clin Oncol       Date:  2021-05-25

6.  Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology.

Authors:  Mathieu Hatt; Dimitris Visvikis; Nidal M Albarghach; Florent Tixier; Olivier Pradier; Catherine Cheze-le Rest
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-03-02       Impact factor: 9.236

7.  Prognostic Significance of Volume-based Metabolic Parameters by (18)F-FDG PET/CT in Gallbladder Carcinoma.

Authors:  Jang Yoo; Joon Young Choi; Kyu Taek Lee; Jin Seok Heo; Soo Bin Park; Seung Hwan Moon; Yearn Seong Choe; Kyung-Han Lee; Byung-Tae Kim
Journal:  Nucl Med Mol Imaging       Date:  2012-06-19

8.  18FDG uptake in oesophageal adenocarcinoma: linking biology and outcome.

Authors:  Marinke Westerterp; Gerrit W Sloof; Otto S Hoekstra; Fiebo J W Ten Kate; Gerrit A Meijer; Johannes B Reitsma; Ronald Boellaard; J Jan B van Lanschot; Carla F M Molthoff
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-25       Impact factor: 4.553

9.  Positron emission tomography changes management and prognostic stratification in patients with oesophageal cancer: results of a multicentre prospective study.

Authors:  B E Chatterton; I Ho Shon; A Baldey; N Lenzo; A Patrikeos; B Kelley; D Wong; J E Ramshaw; A M Scott
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-10-18       Impact factor: 9.236

10.  Does the value of PET-CT extend beyond pretreatment staging? An analysis of survival in surgical patients with esophageal cancer.

Authors:  Boris Sepesi; Daniel P Raymond; Marek Polomsky; Thomas J Watson; Virginia R Litle; Carolyn E Jones; Rui Hu; Xing Qiu; Jeffrey H Peters
Journal:  J Gastrointest Surg       Date:  2009-10-01       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.